Urso Falk


Indications and Reactions:

Role Indications Reactions
Secondary
Pain 12.8%
Hypertension 11.0%
Infection Prophylaxis 11.0%
Arthritis 8.3%
Nausea 6.4%
Graft Versus Host Disease 5.5%
Mineral Supplementation 5.5%
Pyrexia 5.5%
Thrombosis Prophylaxis 4.6%
Fluid Replacement 3.7%
Prophylaxis Against Transplant Rejection 3.7%
Rash 3.7%
Acute Myeloid Leukaemia 2.8%
Drug Use For Unknown Indication 2.8%
Oral Candidiasis 2.8%
Sepsis 2.8%
Antiviral Prophylaxis 1.8%
Anxiety 1.8%
Cholelithiasis 1.8%
Chronic Myeloid Leukaemia 1.8%
Toxic Epidermal Necrolysis 55.6%
Klebsiella Sepsis 22.2%
Hepatic Lesion 11.1%
Hepatic Neoplasm Malignant Recurrent 11.1%
Concomitant
Drug Use For Unknown Indication 15.4%
Prophylaxis Against Transplant Rejection 9.1%
Hypertension 9.0%
Product Used For Unknown Indication 8.4%
Prophylaxis 7.4%
Liver Transplant 7.0%
Infection Prophylaxis 5.1%
Diabetes Mellitus 4.2%
Pain 3.6%
Colitis Ulcerative 3.4%
Crohn's Disease 3.3%
Sleep Disorder 3.1%
Immunosuppression 3.0%
Graft Versus Host Disease 2.9%
Hepatic Neoplasm Malignant 2.8%
Prophylaxis Against Gastrointestinal Ulcer 2.8%
Thrombosis Prophylaxis 2.7%
Antiviral Prophylaxis 2.5%
Hepatitis C 2.4%
Renal Failure 2.3%
Thrombocytopenia 12.3%
Hepatic Neoplasm Malignant Recurrent 8.4%
Renal Failure 7.1%
Vomiting 7.1%
Lung Adenocarcinoma 6.5%
Sepsis 6.5%
Haemolysis 5.2%
Toxic Epidermal Necrolysis 5.2%
Liver Transplant Rejection 4.5%
Weight Decreased 4.5%
Hepatic Fibrosis 3.9%
Stenotrophomonas Infection 3.9%
Vanishing Bile Duct Syndrome 3.9%
Cellulitis 3.2%
Lactic Acidosis 3.2%
Liver Function Test Abnormal 3.2%
Metastases To Bone 3.2%
Urinary Tract Infection 3.2%
Haemoptysis 2.6%
Portal Vein Thrombosis 2.6%

Drug Data